OpenOnco
UA EN

Onco Wiki / Препарат

Doxazosin

Детермінований перегляд YAML-сутності з джерельної бази. Клінічний авторитет лишається за вказаними source ID та статусом клінічного sign-off.

IDDRUG-DOXAZOSIN
ТипПрепарат
Синоніми
Carduraselective alpha-1 blockerДоксазозин
Статуспереглянуто 2026-07-11 | очікує клінічного підпису
ХворобиDIS-PHEOCHROMOCYTOMA
ДжерелаSRC-ENDOCRINE-SOCIETY-PPGL-2014 SRC-NCCN-NET-2025

Дані про препарат

КласSelective, competitive alpha-1 adrenergic receptor antagonist
Механізм діїSelectively and reversibly blocks post-synaptic alpha-1 adrenergic receptors, reducing catecholamine-mediated peripheral vasoconstriction with less reflex tachycardia than non-selective irreversible agents (phenoxybenzamine) because alpha-2 presynaptic auto-inhibition of norepinephrine release is preserved. Used as an alternative preoperative alpha-blocker in pheochromocytoma / paraganglioma (PPGL) where mandatory preoperative alpha-blockade is required before surgery to prevent intraoperative hypertensive crisis (Endocrine Society 2014 PPGL guideline).
Типове дозуванняStarting dose typically 1-2 mg PO once daily, titrated upward every few days as tolerated toward blood-pressure normalization and symptom control ahead of PPGL surgery, per Endocrine Society 2014 PPGL guideline (SRC-ENDOCRINE-SOCIETY-PPGL-2014); usual ceiling in general antihypertensive use is 16 mg/day, though the dose actually required for adequate preoperative PPGL blockade is individualized by the treating team. Usual preoperative course runs roughly one to two weeks before surgery. Exact target BP/HR thresholds are NOT fixed numeric values in this stub -- see RF-PHEO-INADEQUATE-ALPHA-BLOCKADE for the hard sequencing gate this drug exists to satisfy.
Зареєстровано в УкраїніTrue
Відшкодовується НСЗУFalse
Остання перевірка для України2026-07-11

Нотатки

Selective alpha-1 blockade gives less reflex tachycardia and easier general availability than phenoxybenzamine (DRUG-PHENOXYBENZAMINE), making doxazosin a commonly used practical alternative for mandatory preoperative PPGL alpha-blockade; choice between the two is per local practice/availability, not modelled as a KB-level preference. STUB pending clinical co-lead signoff (CHARTER §6.1, dev-mode-exempted).

Де використовується

Regimens

Препарат